MediciNova
MNOV
35 hedge funds and large institutions have $17.6M invested in MediciNova in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 17 reducing their positions, and 0 closing their positions.
9% more funds holding
Funds holding: 32 → 35 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.35% less ownership
Funds ownership: 14.54% → 14.19% (-0.35%)
7% less capital invested
Capital invested by funds: $19M → $17.6M (-$1.43M)
82% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$76K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$66K |
| 3 |
Renaissance Technologies
New York
|
+$29.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.15K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$301K |
| 2 |
Millennium Management
New York
|
-$57.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$55.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$52.3K |
| 5 |
JP Morgan Chase
New York
|
-$33.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BF
26
Blankinship & Foster
Solana Beach,
California
| $40K | – | – | – |
|
27
Morgan Stanley
New York
| $38K | -$128 | -49 | -0.3% |
|
|
WA
28
WealthTrust Axiom
Wayne,
Pennsylvania
| $31K | – | – | – |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $20K | +$9.15K | +3,508 | +78% |
|
|
CG
30
Cutler Group
San Francisco,
California
| $5K | – | – | – |
|
|
CS
31
Credit Suisse
Zurich,
Switzerland
| $3K | +$2.61K | +1,000 | New |
|
32
BNP Paribas Financial Markets
Paris,
France
| $1.04K | -$449 | -172 | -29% |
|
33
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $1K | +$68 | +26 | +9% |
|
MNOV Hedge Fund Activity: Q2 2022 in Review
35 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2022, worth a combined $17.6M — down 7.5% from $19M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MNOV positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 17 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $76K. The largest seller was Susquehanna International Group, cutting an estimated $301K.
- 35 institutional investors held MediciNova (MNOV) as of Q2 2022, up from 32 in Q1 2022.
- Funds reported $17.6M of MediciNova stock for Q2 2022, down 7.5% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q2 2022 and 0 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q2 2022 was Citadel Advisors, an estimated $76K added.
- The largest MediciNova seller in Q2 2022 was Susquehanna International Group, an estimated $301K sold.
Based on aggregated 13F filings for Q2 2022.